Company: AEMD
Filing Date: 2025-08-29
Form Type: CORRESP
Source: 0001683168-25-006557
Chunk: 0

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-29
Form: CORRESP
Chunk 0
---
<div align='center'>MAXIM GROUP LLC

300 Park Avenue, 16 thFloor
New York, New York 10022</div>

August 29, 2025

VIA EDGAR CORRESPONDENCE

U.S. Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.
Washington, D.C. 20549

| Re: | Aethlon Medical, Inc.                          
 Registration Statement on Form S-1, as amended |
|     | File No. 333-289745                            |

Ladies and Gentlemen:

Pursuant to Rule 461 of the
General Rules and Regulations under the Securities Act of 1933, as amended (the “Act”), we, the underwriter, hereby request
that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced registration
statement on Form S-1 (the “Registration Statement”) to become effective at 5:01 p.m., Eastern time, on Tuesday, September
2, 2025, or as soon thereafter as practicable.

Pursuant to Rule 460 under
the Act, we wish to advise you that we have distributed as many copies of the Preliminary Prospectus dated August 29, 2025 to agents,
dealers, institutions and others as appears to be reasonable to secure adequate distribution of the preliminary prospectus.

The undersigned, as underwriter,
has complied and will comply with Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. If you require any additional information
with respect to this letter, please contact M. Ali Panjwani at (212) 326-0820 of Pryor Cashman LLP.

| Very truly yours,             
 MAXIM GROUP LLC               
 By: /s/ Ritesh M. Veera       
 Ritesh M. Veera               
 Co-Head of Investment Banking |

| cc: | M. Ali Panjwani, Esq. |
|     | Pryor Cashman LLP     |